Victoza (liraglutide) solution for injection is prescribed to help manage blood sugar and reduce major heart-related risks. Victoza is not safe to use while pregnant and may not be safe to use while ...

COPENHAGEN, Sept 13 (Reuters) - Danish drugmaker Novo Nordisk said new data showed people with type 2 diabetes experienced improvements in controlling blood sugar levels when using its diabetes drug ...

LONDON (Reuters) - Novo Nordisk's big new drug hope Victoza has been recommended for limited use on Britain's state-run health service as a treatment for diabetes, the Danish drugmaker said on Monday.

(Reuters) -Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's Victoza to treat patients with type 2 diabetes, making it the first generic GLP-1 drug in the United ...

Novo Nordisk A/S (NYSE: NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed to delay generic competition. • What’s ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the treatment ...

Novo Nordisk's Victoza, a popular diabetes medication, has shown mixed results in a mid-stage trial targeting Alzheimer's disease. While the drug failed to meet its primary endpoint of improving brain ...

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold under the brand names Victoza and Saxenda. Read on for everything you need ...

Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic ...

Danish pharmaceutical giant Novo Nordisk was hit with ‍a class action lawsuit in New York federal court on Friday for allegedly ⁠misusing its patents to maintain a monopoly on its diabetes drug ...